Article Details
Retrieved on: 2023-01-10 16:20:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
TAIPEI, Taiwan -- Chinese health care authorities declined to include Pfizer's COVID-19 treatment drug in a national reimbursement list that would ...
Article found on: www.hotsr.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here